The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective, phase II, single-arm study of neoadjuvant/conversion therapy with camrelizumab, apatinib, S-1 ± oxaliplatin for locally advanced cT4a/bN+ gastric cancer.
 
Song Li
No Relationships to Disclose
 
Wenbin Yu
No Relationships to Disclose
 
Fei Xie
No Relationships to Disclose
 
Zhimin Liu
No Relationships to Disclose
 
Weiwei Lv
No Relationships to Disclose
 
Duanbo Shi
No Relationships to Disclose
 
Dexin Yu
No Relationships to Disclose
 
Meng Wei
No Relationships to Disclose
 
Jiaqian Wang
Employment - Yuce Biotechnology
 
Yongtian Zhao
Employment - Yuce Biotechnology
 
Cheng Chen
No Relationships to Disclose
 
Zhikun Zhao
Employment - Yuce Biotechnology
 
Jing Gao
No Relationships to Disclose
 
Lei Sheng
No Relationships to Disclose
 
Lian Liu
No Relationships to Disclose